| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 1589 |
| 1 | ADALIMUMAB | 1365 |
| 2 | USTEKINUMAB | 512 |
| 3 | RISANKIZUMAB-RZAA | 499 |
| 4 | PREDNISONE | 317 |
| 5 | AZATHIOPRINE | 272 |
| 6 | VEDOLIZUMAB | 261 |
| 7 | METHOTREXATE SODIUM | 190 |
| 8 | METHOTREXATE | 175 |
| 9 | UPADACITINIB | 171 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 141 | 0.0409 |
| 1 | MAFENIDE ACETATE | 1 | 0.0323 |
| 2 | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE | 1 | 0.0167 |
| 3 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 4 | 0.0135 |
| 4 | AESCULUS HIPPOCASTANUM WHOLE | 1 | 0.0133 |
| 5 | AGRIMONIA EUPATORIA | 1 | 0.0132 |
| 6 | CENTAURIUM ERYTHRAEA | 1 | 0.0130 |
| 7 | INFLIXIMAB | 1589 | 0.0072 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 26 | 0.0065 |
| 9 | COLESTIPOL HYDROCHLORIDE | 16 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1891 |
| 1 | Interleukin-23 Antagonist [EPC] | 1016 |
| 2 | Interleukin-12 Antagonist [EPC] | 513 |
| 3 | Corticosteroid [EPC] | 468 |
| 4 | Integrin Receptor Antagonist [EPC] | 288 |
| 5 | Purine Antimetabolite [EPC] | 272 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 175 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 173 |
| 8 | Janus Kinase Inhibitor [EPC] | 171 |
| 9 | Provitamin D2 Compound [EPC] | 145 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 1016 | 0.0097 |
| 1 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 3 | Interleukin-12 Antagonist [EPC] | 513 | 0.0049 |
| 4 | Provitamin D2 Compound [EPC] | 145 | 0.0049 |
| 5 | Integrin Receptor Antagonist [EPC] | 288 | 0.0033 |
| 6 | Bile Acid Sequestrant [EPC] | 35 | 0.0029 |
| 7 | Purine Antimetabolite [EPC] | 272 | 0.0028 |
| 8 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 1891 | 0.0019 |